Chapman H A, Stahl M, Allen C L, Yee R, Fair D S
Department of Medicine, University of Utah School of Medicine, Salt Lake City.
Am Rev Respir Dis. 1988 Jun;137(6):1417-25. doi: 10.1164/ajrccm/137.6.1417.
The nature of the procoagulant activity of normal bronchoalveolar fluid was examined both qualitatively and quantitatively. Unconcentrated, cell-free lavage freshly obtained from normal volunteers clotted normal plasma in a mean of 84 +/- 20 s. The procoagulant activity was initiated by Factor VII-tissue factor complexes as judged by differential activity in various plasmas genetically deficient in single clotting factors, by neutralization of the procoagulant activity with antibodies to either Factor VII or tissue factor, and by a Factor X activation assay. Preincubation of the lavage with calcium was required to demonstrate Factor VII activity in unconcentrated samples. The cell-free fluid contained about 8,500 thromboplastin units/mg protein, equivalent to a third of the thromboplastin standard and indicating high amounts of cofactor. Quantitation of Factor VII was estimated by functional analysis in coagulation and amidolytic assays with reference to dilutions of normal plasma of known Factor VII concentration. When lavage and diluted plasma were adjusted to yield equivalent amidolytic activities, the average ratio of the Factor VII-clotting activity of the alveolar fluid relative to plasma Factor VII was 19 +/- 7, suggesting the presence of Factor VIIa in lavage. In contrast to previous reports with serum or activated plasma, immunoblots of concentrated lavage revealed only single-chain Factor VII, and 125I-Factor VII added to the fluid was not converted to 125I-Factor VIIa, suggesting a unique control mechanism in the lung compartment which differs from plasma. When equivalent Factor VII amidolytic activities in diluted plasma and cell-free lavage were compared, the rates of Factor Xa formation were very similar.(ABSTRACT TRUNCATED AT 250 WORDS)
对正常支气管肺泡液促凝活性的性质进行了定性和定量研究。从正常志愿者新鲜获取的未浓缩、无细胞灌洗液使正常血浆平均在84±20秒内凝固。通过在单一凝血因子基因缺陷的各种血浆中的差异活性、用抗因子VII或组织因子的抗体中和促凝活性以及因子X激活试验判断,促凝活性由因子VII - 组织因子复合物启动。灌洗液与钙预温育是证明未浓缩样品中因子VII活性所必需的。无细胞液每毫克蛋白质含有约8500个凝血活酶单位,相当于凝血活酶标准的三分之一,表明辅因子含量高。通过凝血功能分析和酰胺水解试验并参照已知因子VII浓度的正常血浆稀释液来估计因子VII的定量。当灌洗液和稀释血浆调整至产生等效酰胺水解活性时,肺泡液中因子VII促凝活性相对于血浆因子VII的平均比值为19±7,提示灌洗液中存在因子VIIa。与先前关于血清或活化血浆的报道相反,浓缩灌洗液的免疫印迹仅显示单链因子VII,加入该液体中的125I - 因子VII未转化为125I - 因子VIIa,提示肺腔室中存在不同于血浆的独特控制机制。当比较稀释血浆和无细胞灌洗液中等效因子VII酰胺水解活性时,因子Xa形成速率非常相似。(摘要截短于250字)